ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $244,000 | +16.7% | 8,512 | -14.6% | 0.01% | +11.1% |
| Q1 2017 | $209,000 | -21.1% | 9,966 | -29.3% | 0.01% | -25.0% |
| Q4 2016 | $265,000 | -25.6% | 14,100 | +69.4% | 0.01% | -29.4% |
| Q4 2015 | $356,000 | +17.5% | 8,322 | -8.5% | 0.02% | +30.8% |
| Q2 2015 | $303,000 | -17.2% | 9,100 | -17.3% | 0.01% | -7.1% |
| Q1 2015 | $366,000 | +25.3% | 11,010 | +54.1% | 0.01% | +16.7% |
| Q4 2014 | $292,000 | +35.2% | 7,146 | +12.3% | 0.01% | +20.0% |
| Q3 2014 | $216,000 | -81.2% | 6,366 | -81.3% | 0.01% | -80.0% |
| Q2 2014 | $1,146,000 | -24.3% | 34,000 | -14.8% | 0.05% | -27.5% |
| Q1 2014 | $1,513,000 | +37.7% | 39,918 | +6.1% | 0.07% | +40.8% |
| Q4 2013 | $1,099,000 | +11.5% | 37,634 | +30.8% | 0.05% | -5.8% |
| Q3 2013 | $986,000 | +10.0% | 28,765 | +5.9% | 0.05% | -17.5% |
| Q2 2013 | $896,000 | – | 27,162 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
| ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
| SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
| Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
| ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
| Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
| Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |